Spatial mapping of immune cell environments in NF2-related schwannomatosis vestibular schwannoma

被引:0
|
作者
Jones, Adam P. [1 ,2 ]
Haley, Michael J. [1 ,2 ]
Meadows, Miriam H. [1 ,2 ]
Gregory, Grace E. [2 ,3 ]
Hannan, Cathal J. [2 ,4 ]
Simmons, Ana K. [1 ]
Bere, Leoma D. [1 ,2 ]
Lewis, Daniel G. [2 ,4 ]
Oliveira, Pedro [5 ]
Smith, Miriam J. [2 ,6 ]
King, Andrew T. [2 ,4 ]
Evans, D. Gareth R. [2 ,6 ]
Paszek, Pawel [1 ,7 ]
Brough, David [2 ,3 ]
Pathmanaban, Omar N. [2 ,3 ,4 ]
Couper, Kevin N. [1 ,2 ]
机构
[1] Univ Manchester, Fac Biol Med & Hlth, Div Immunol Immun Infect & Resp Med, Manchester, England
[2] Univ Manchester, Northern Care Alliance NHS Fdn Trust, Geoffrey Jefferson Brain Res Ctr, Manchester Acad Hlth Sci Ctr, Manchester, England
[3] Univ Manchester, Fac Biol Med & Hlth, Div Neurosci, Manchester, England
[4] Salford Royal Hosp NHS Fdn Trust, Manchester Ctr Clin Neurosci, Dept Neurosurg, Salford, England
[5] Christie Hosp, Dept Pathol, Manchester, England
[6] Univ Manchester, Fac Biol Med & Hlth, Div Evolut Infect & Genom, Manchester, England
[7] Polish Acad Sci, Inst Fundamental Technol Res, Dept Biosyst & Soft Matter, Warsaw, Poland
基金
英国医学研究理事会;
关键词
GERM-LINE MUTATIONS; SINGLE-CELL; NEUROFIBROMATOSIS TYPE-2; T-CELLS; NF2; BEVACIZUMAB; SEVERITY; GENE; EXPRESSION; LANDSCAPE;
D O I
10.1038/s41467-025-57586-z
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
NF2-related Schwannomatosis (NF2 SWN) is a rare disease characterised by the growth of multiple nervous system neoplasms, including bilateral vestibular schwannoma (VS). VS tumours are characterised by extensive leucocyte infiltration. However, the immunological landscape in VS and the spatial determinants within the tumour microenvironment that shape the trajectory of disease are presently unknown. In this study, to elucidate the complex immunological networks across VS, we performed imaging mass cytometry (IMC) on clinically annotated VS samples from NF2 SWN patients. We reveal the heterogeneity in neoplastic cell, myeloid cell and T cell populations that co-exist within VS, and that distinct myeloid cell and Schwann cell populations reside within varied spatial contextures across characteristic Antoni A and B histomorphic niches. Interestingly, T-cell populations co-localise with tumour-associated macrophages (TAMs) in Antoni A regions, seemingly limiting their ability to interact with tumorigenic Schwann cells. This spatial landscape is altered in Antoni B regions, where T-cell populations appear to interact with PD-L1+ Schwann cells. We also demonstrate that prior bevacizumab treatment (VEGF-A antagonist) preferentially reduces alternatively activated-like TAMs, whilst enhancing CD44 expression, in bevacizumab-treated tumours. Together, we describe niche-dependent modes of T-cell regulation in NF2 SWN VS, indicating the potential for microenvironment-altering therapies for VS.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Bevacizumab Treatment for Patients with NF2-Related Schwannomatosis: A Single Center Experience
    Douwes, Jules P. J.
    Hensen, Erik F.
    Jansen, Jeroen C.
    Gelderblom, Hans
    Schopman, Josefine E.
    CANCERS, 2024, 16 (08)
  • [32] ACTIVITY OF BEVACIZUMAB AGAINST NF2-RELATED VESTIBULAR SCHWANNOMAS
    Plotkin, Scott
    Halpin, Christopher
    Stemmer-Rachamimov, Anat
    Barker, Fred
    Sorensen, Gregory
    Jain, Rakesh
    Di Tomaso, Emmanuelle
    NEURO-ONCOLOGY, 2008, 10 (05) : 796 - 796
  • [33] Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases
    Dhaenens, Britt A. E.
    Heimann, Guenter
    Bakker, Annette
    Nievo, Marco
    Ferner, Rosalie E.
    Evans, D. Gareth
    Wolkenstein, Pierre
    Leubner, Jonas
    Potratz, Cornelia
    Carton, Charlotte
    Iloeje, Uchenna
    Kirk, George
    Blakeley, Jaishri O.
    Plotkin, Scott
    Fisher, Michael J.
    Kim, Aerang
    Driever, Pablo Hernaiz
    Azizi, Amedeo A.
    Widemann, Brigitte C.
    Gross, Andrea
    Parke, Tom
    Legius, Eric
    Oostenbrink, Rianne
    NEURO-ONCOLOGY PRACTICE, 2024, 11 (04) : 395 - 403
  • [34] Expanding therapeutic options for people with NF2-related schwannomatosis: Encouraging results with brigatinib
    Plotkin, Scott R.
    Blakeley, Jaishri O.
    NEURO-ONCOLOGY, 2024, 26 (11) : 1949 - 1950
  • [35] A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma
    Chen, Jie
    Landegger, Lukas D.
    Sun, Yao
    Ren, Jun
    Maimon, Nir
    Wu, Limeng
    Ng, Mei R.
    Chen, John W.
    Zhang, Na
    Zhao, Yingchao
    Gao, Xing
    Fujita, Takeshi
    Roberge, Sylvie
    Huang, Peigen
    Jain, Rakesh K.
    Plotkin, Scott R.
    Stankovic, Konstantina M.
    Xu, Lei
    NATURE PROTOCOLS, 2019, 14 (02) : 541 - 555
  • [36] SINGLE-INSTITUTION SERIES OF SPINAL EPENDYMOMA IN CHILDREN WITH NF2-RELATED SCHWANNOMATOSIS
    Burket, Noah
    Koenig, Jenna
    Tailor, Jignesh
    NEURO-ONCOLOGY, 2023, 25
  • [37] A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma
    Jie Chen
    Lukas D. Landegger
    Yao Sun
    Jun Ren
    Nir Maimon
    Limeng Wu
    Mei R. Ng
    John W. Chen
    Na Zhang
    Yingchao Zhao
    Xing Gao
    Takeshi Fujita
    Sylvie Roberge
    Peigen Huang
    Rakesh K. Jain
    Scott R Plotkin
    Konstantina M. Stankovic
    Lei Xu
    Nature Protocols, 2019, 14 : 541 - 555
  • [38] The impact of mental health on health-related quality of life in patients with NF2-related Schwannomatosis
    Freier, Anna
    Lawson McLean, Anna C.
    Loeschner, Denise
    Rosahl, Steffen K.
    Kruse, Johannes
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [39] Comprehensive bioinformatics analysis of lncRNA regulation and screening for pathogenic genes in NF2-related schwannomatosis
    Chen, Zhuming
    Li, Kai
    Mofatteh, Mohammad
    Guo, Weitao
    Pan, Lei
    Wang, Qingsong
    ONCOLOGIE, 2024, 26 (06) : 1055 - 1064
  • [40] Updated protocol for genetic testing, screening and clinical management of individuals at risk of NF2-related schwannomatosis
    Halliday, Dorothy
    Emmanouil, Beatrice
    Evans, D. Gareth R.
    CLINICAL GENETICS, 2023, 103 (05) : 540 - 552